Grants and Contributions:

Back to search
Title:
Antibiotic Replacement Project
Agreement Number:
924891
Agreement Value:
$41,210.00
Agreement Date:
Apr 1, 2019 - Jun 30, 2019
Description:
MicroSintesis will be testing the efficacy of proteobiotics and their ability to reduce Necrotic Enteritis in poultry. A proteobiotic dose response will be compared to a commercial antibiotic used to treat Necrotic Enteritis.
Organization:
National Research Council Canada
Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:
Carstairs, Prince Edward Island, CA C1A 4L1
Reference Number:
172-2019-2020-Q1-924891
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
843481516
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The total amended value is 41,210 dollars.

Amendment Date
May 6, 2019
Recipient's Legal Name:
MicroSintesis Inc.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments:
See Amendments